You can buy or sell PRLD and other stocks, options, and ETFs commission-free!
Prelude Therapeutics, Inc. operates as a cancer drug discovery company. It focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Gopi Krishna Vaddi in 2016 and is headquartered in Wilmington, DE. The listed name for PRLD is Prelude Therapeutics Incorporated Common Stock.
52 Week High
52 Week Low
— per share
Expected Feb 24, Pre-Market